FOXC1 source guide

The review covers 143 original QuickGO contexts represented by 141 stored annotations: 38 ACCEPT, 44 KEEP_AS_NON_CORE, 38 TOO_GENERAL, 6 MODIFY and 15 UNDECIDED. It contains two core functions, no NEW annotations and no publication quotations. All 40 normal source files are preserved unchanged after acquisition.

The cores are selective regulatory DNA binding coupled to positive RNA polymerase II transcription, and GLI2 binding that enhances GLI2 DNA binding in the tested human breast-cancer models. Both act in the nucleus. Developmental, growth, migration and differentiation effects retain their tissue and experimental context. The binding refinements describe supported partner classes; co-complex evidence is not silently promoted to purified binary binding.

Campaign decision policy

The explicit ClinGen campaign instruction retains supported, biologically correct generic protein-binding associations as KEEP_AS_NON_CORE when no evidence-backed functional subtype is established. It expressly records the user’s task-specific departure from the skill’s informational-exclusion recommendation. This instruction applies to new reviews in this campaign; it is independent of the repository validator’s legacy carve-out. The C1QBP/p32 and HIV-fragment rows retain positive evidence at their stated assay scope and do not acquire a guessed functional subtype.

Deterministic projection

The genuine exporter produced 143 TSV rows and the genuine seed contained 141 annotation keys. Original raw rows 36/37 (FLNA, PMID:15684392) share stored row 45; rows 46/47 (DNA bending, PMID:7957066) share stored row 83. The full original objects, assigners, dates, WITH/FROM alternatives, extensions and raw-to-TSV-to-stored joins are retained in FOXC1-contexts.json. No source-context deletion or guessed replacement was made.

Exactly three original singleton extension groups are serialized: raw 17/stored 16 and raw 99/stored 111 have input NCBI_Gene:2308 (FOXO1; RO:0002233); raw 40/stored 48 occurs in GO:0005634 (nucleus; BFO:0000066). Each expression contains one atom, so no OR/conjunction flattening is needed. Raw 51/stored 122 has no extension.

The target label FOXO1 is the official NCBI Gene:2308 symbol. Predicate labels follow the official Relation Ontology process-relations documentation and BFO term record. The source fields retain the original human target, evidence, qualifier, reference and supporting entities.

Access and uncertainty

The source evidence map states original-reading scope separately from normal-cache availability. Original author/publisher/PMC sections sometimes provided stronger access than an unchanged abstract-only cache. A successful HTML response or a file named PDF/XLSX was not treated as source access when its content was a challenge page. Supplementary tables and image pixels are not claimed where uninspected.

Fifteen unresolved rows retain their specific missing evidence: the PMID:11237714 activation assertion; the three PMID:19793056 letter contexts; PMID:14506133 DNA bending; the separate PMID:25609649 PBX1 interaction; mouse negative Pol-II regulation and positive stem/progenitor differentiation; the lens-versus-cornea transfer; and PMID:25808752 core-promoter binding. Successful assays in other papers do not replay those source-specific contexts.

The authentic PMID:11237714 abstract foregrounds DSCAM, but full-text inaccessibility does not establish a wrong-gene error. Mouse Q61572 is Foxc1 and Q61850 is Foxc2; the renal paper directly studies Foxc1 as well as compound dosage. Donor identity or donor count alone does not invalidate a transfer.

Products and phylogeny

The official reviewed Q12948 record has a 553-aa displayed sequence and no enumerated alternative natural products. Human patient substitutions, engineered deletions, inducible FOXC1 fusions, bacterial GST domains and partner products are not added as natural FOXC1 products.

All six PAINT origins were replayed against the actual tree, MSA and original IBD source. The two donor/date snapshot differences remain intact; the review does not turn an inherited function into a new annotation.

Original context index

Raw Stored Original context ID GO Evidence Reference Assigner
0 19 UniProtKB:Q12948!28906821 GO:0001654 IDA PMID:9792859 MGI
1 79 UniProtKB:Q12948!28906822 GO:0007507 IDA PMID:10474162 MGI
2 106 UniProtKB:Q12948!28906823 GO:0045893 IDA PMID:11237714 MGI
3 9 UniProtKB:Q12948!28906824 GO:0000976 ISS GO_REF:0000024 BHF-UCL
4 8 UniProtKB:Q12948!28906825 GO:0000976 IEA GO_REF:0000107 Ensembl
5 4 UniProtKB:Q12948!28906826 GO:0000976 IDA PMID:17210863 UniProt
6 5 UniProtKB:Q12948!28906827 GO:0000976 IDA PMID:19279310 UniProt
7 6 UniProtKB:Q12948!28906828 GO:0000976 IDA PMID:25786029 UniProt
8 7 UniProtKB:Q12948!28906829 GO:0000976 IDA PMID:27804176 UniProt
9 10 UniProtKB:Q12948!28906830 GO:0000977 IDA PMID:7957066 NTNU_SB
10 11 UniProtKB:Q12948!28906831 GO:0000978 IBA GO_REF:0000033 GO_Central
11 12 UniProtKB:Q12948!28906832 GO:0000978 IEA GO_REF:0000107 Ensembl
12 13 UniProtKB:Q12948!28906833 GO:0000981 IBA GO_REF:0000033 GO_Central
13 14 UniProtKB:Q12948!28906834 GO:0000981 IEA GO_REF:0000107 Ensembl
14 15 UniProtKB:Q12948!28906835 GO:0000981 ISA GO_REF:0000113 NTNU_SB
15 18 UniProtKB:Q12948!28906836 GO:0001228 ISS GO_REF:0000024 UniProt
16 17 UniProtKB:Q12948!28906837 GO:0001228 IEA GO_REF:0000107 Ensembl
17 16 UniProtKB:Q12948!28906838 GO:0001228 IDA PMID:17993506 NTNU_SB
18 27 UniProtKB:Q12948!28906839 GO:0003677 IDA PMID:11179011 MGI
19 28 UniProtKB:Q12948!28906840 GO:0003677 IDA PMID:15684392 UniProt
20 29 UniProtKB:Q12948!28906841 GO:0003677 IDA PMID:7957066 MGI
21 38 UniProtKB:Q12948!28906842 GO:0003700 IEA GO_REF:0000120 UniProt
22 30 UniProtKB:Q12948!28906843 GO:0003700 IDA PMID:11179011 MGI
23 31 UniProtKB:Q12948!28906844 GO:0003700 IDA PMID:11782474 UniProt
24 32 UniProtKB:Q12948!28906845 GO:0003700 IDA PMID:14506133 UniProt
25 33 UniProtKB:Q12948!28906846 GO:0003700 IDA PMID:14578375 UniProt
26 39 UniProtKB:Q12948!28906847 GO:0003700 IMP PMID:14578375 UniProt
27 34 UniProtKB:Q12948!28906848 GO:0003700 IDA PMID:15277473 UniProt
28 35 UniProtKB:Q12948!28906849 GO:0003700 IDA PMID:15299087 UniProt
29 36 UniProtKB:Q12948!28906850 GO:0003700 IDA PMID:15684392 UniProt
30 40 UniProtKB:Q12948!28906851 GO:0003700 IMP PMID:16449236 UniProt
31 41 UniProtKB:Q12948!28906852 GO:0003700 IMP PMID:17210863 UniProt
32 42 UniProtKB:Q12948!28906853 GO:0003700 IMP PMID:19279310 UniProt
33 43 UniProtKB:Q12948!28906854 GO:0003700 IMP PMID:19793056 UniProt
34 44 UniProtKB:Q12948!28906855 GO:0003700 IMP PMID:25786029 UniProt
35 37 UniProtKB:Q12948!28906856 GO:0003700 IDA PMID:27804176 UniProt
36 45 UniProtKB:Q12948!28906857 GO:0005515 IPI PMID:15684392 UniProt
37 45 UniProtKB:Q12948!28906858 GO:0005515 IPI PMID:15684392 IntAct
38 46 UniProtKB:Q12948!28906859 GO:0005515 IPI PMID:15684392 IntAct
39 47 UniProtKB:Q12948!28906860 GO:0005515 IPI PMID:15684392 UniProt
40 48 UniProtKB:Q12948!28906861 GO:0005515 IPI PMID:16449236 IntAct
41 49 UniProtKB:Q12948!28906862 GO:0005515 IPI PMID:18676636 IntAct
42 50 UniProtKB:Q12948!28906863 GO:0005515 IPI PMID:22190034 IntAct
43 51 UniProtKB:Q12948!28906864 GO:0005515 IPI PMID:25609649 IntAct
44 52 UniProtKB:Q12948!28906865 GO:0005515 IPI PMID:26565916 UniProt
45 82 UniProtKB:Q12948!28906866 GO:0008301 IDA PMID:14506133 UniProt
46 83 UniProtKB:Q12948!28906867 GO:0008301 IDA PMID:7957066 UniProt
47 83 UniProtKB:Q12948!28906868 GO:0008301 IDA PMID:7957066 MGI
48 104 UniProtKB:Q12948!28906869 GO:0043565 IEA GO_REF:0000002 InterPro
49 102 UniProtKB:Q12948!28906870 GO:0043565 IDA PMID:15277473 UniProt
50 103 UniProtKB:Q12948!28906871 GO:0043565 IDA PMID:7957066 UniProt
51 122 UniProtKB:Q12948!28906872 GO:0061629 IPI PMID:16449236 UniProt
52 128 UniProtKB:Q12948!28906873 GO:0140297 IPI PMID:15684392 UniProt
53 138 UniProtKB:Q12948!28906874 GO:1990841 ISS GO_REF:0000024 UniProt
54 137 UniProtKB:Q12948!28906875 GO:1990841 IEA GO_REF:0000107 Ensembl
55 1 UniProtKB:Q12948!28906876 GO:0000122 ISS GO_REF:0000024 UniProt
56 0 UniProtKB:Q12948!28906877 GO:0000122 IEA GO_REF:0000107 Ensembl
57 20 UniProtKB:Q12948!28906878 GO:0001657 ISS GO_REF:0000024 UniProt
58 21 UniProtKB:Q12948!28906879 GO:0001657 ISS GO_REF:0000024 UniProt
59 22 UniProtKB:Q12948!28906880 GO:0001756 IEA GO_REF:0000107 Ensembl
60 23 UniProtKB:Q12948!28906881 GO:0001822 ISS GO_REF:0000024 UniProt
61 24 UniProtKB:Q12948!28906882 GO:0001822 ISS GO_REF:0000024 UniProt
62 26 UniProtKB:Q12948!28906883 GO:0001958 ISS GO_REF:0000024 UniProt
63 25 UniProtKB:Q12948!28906884 GO:0001958 IEA GO_REF:0000107 Ensembl
64 77 UniProtKB:Q12948!28906885 GO:0006355 IEA GO_REF:0000002 InterPro
65 73 UniProtKB:Q12948!28906886 GO:0006355 IDA PMID:11782474 UniProt
66 74 UniProtKB:Q12948!28906887 GO:0006355 IDA PMID:14506133 UniProt
67 75 UniProtKB:Q12948!28906888 GO:0006355 IDA PMID:15299087 UniProt
68 76 UniProtKB:Q12948!28906889 GO:0006355 IDA PMID:15684392 UniProt
69 78 UniProtKB:Q12948!28906890 GO:0006357 IBA GO_REF:0000033 GO_Central
70 80 UniProtKB:Q12948!28906891 GO:0008283 IDA PMID:20406990 UniProt
71 81 UniProtKB:Q12948!28906892 GO:0008283 IMP PMID:22991501 UniProt
72 84 UniProtKB:Q12948!28906893 GO:0009653 IBA GO_REF:0000033 GO_Central
73 85 UniProtKB:Q12948!28906894 GO:0010628 IEA GO_REF:0000107 Ensembl
74 86 UniProtKB:Q12948!28906895 GO:0010718 IMP PMID:22991501 UniProt
75 88 UniProtKB:Q12948!28906896 GO:0014031 ISS GO_REF:0000024 UniProt
76 87 UniProtKB:Q12948!28906897 GO:0014031 IEA GO_REF:0000107 Ensembl
77 89 UniProtKB:Q12948!28906898 GO:0016477 IDA PMID:20406990 UniProt
78 90 UniProtKB:Q12948!28906899 GO:0016477 IMP PMID:22991501 UniProt
79 92 UniProtKB:Q12948!28906900 GO:0016525 ISS GO_REF:0000024 UniProt
80 91 UniProtKB:Q12948!28906901 GO:0016525 IEA GO_REF:0000107 Ensembl
81 94 UniProtKB:Q12948!28906902 GO:0021549 ISS GO_REF:0000024 UniProt
82 93 UniProtKB:Q12948!28906903 GO:0021549 IEA GO_REF:0000107 Ensembl
83 95 UniProtKB:Q12948!28906904 GO:0030154 IBA GO_REF:0000033 GO_Central
84 97 UniProtKB:Q12948!28906905 GO:0036438 ISS GO_REF:0000024 UniProt
85 96 UniProtKB:Q12948!28906906 GO:0036438 IEA GO_REF:0000107 Ensembl
86 99 UniProtKB:Q12948!28906907 GO:0038084 ISS GO_REF:0000024 UniProt
87 98 UniProtKB:Q12948!28906908 GO:0038084 IEA GO_REF:0000107 Ensembl
88 100 UniProtKB:Q12948!28906909 GO:0042475 IMP PMID:12614756 UniProt
89 101 UniProtKB:Q12948!28906910 GO:0043388 IMP PMID:26565916 UniProt
90 105 UniProtKB:Q12948!28906911 GO:0045618 IMP PMID:27907090 UniProt
91 107 UniProtKB:Q12948!28906912 GO:0045893 IDA PMID:15277473 UniProt
92 108 UniProtKB:Q12948!28906913 GO:0045893 NAS PMID:8499623 UniProt
93 109 UniProtKB:Q12948!28906914 GO:0045930 IDA PMID:12408963 UniProt
94 120 UniProtKB:Q12948!28906915 GO:0045944 ISS GO_REF:0000024 BHF-UCL
95 112 UniProtKB:Q12948!28906916 GO:0045944 IMP PMID:14578375 UniProt
96 110 UniProtKB:Q12948!28906917 GO:0045944 IDA PMID:16449236 BHF-UCL
97 113 UniProtKB:Q12948!28906918 GO:0045944 IMP PMID:16492674 UniProt
98 114 UniProtKB:Q12948!28906919 GO:0045944 IMP PMID:17210863 UniProt
99 111 UniProtKB:Q12948!28906920 GO:0045944 IDA PMID:17993506 NTNU_SB
100 115 UniProtKB:Q12948!28906921 GO:0045944 IMP PMID:19279310 UniProt
101 116 UniProtKB:Q12948!28906922 GO:0045944 IMP PMID:19793056 UniProt
102 117 UniProtKB:Q12948!28906923 GO:0045944 IMP PMID:25786029 UniProt
103 118 UniProtKB:Q12948!28906924 GO:0045944 IMP PMID:27804176 UniProt
104 119 UniProtKB:Q12948!28906925 GO:0045944 IMP PMID:27907090 UniProt
105 121 UniProtKB:Q12948!28906926 GO:0048341 IEA GO_REF:0000107 Ensembl
106 124 UniProtKB:Q12948!28906927 GO:0070098 ISS GO_REF:0000024 UniProt
107 123 UniProtKB:Q12948!28906928 GO:0070098 IEA GO_REF:0000107 Ensembl
108 125 UniProtKB:Q12948!28906929 GO:0071364 IMP PMID:16492674 UniProt
109 127 UniProtKB:Q12948!28906930 GO:0072010 ISS GO_REF:0000024 UniProt
110 126 UniProtKB:Q12948!28906931 GO:0072010 IEA GO_REF:0000107 Ensembl
111 129 UniProtKB:Q12948!28906932 GO:0160108 IEA GO_REF:0000117 UniProt
112 131 UniProtKB:Q12948!28906933 GO:1901491 ISS GO_REF:0000024 UniProt
113 130 UniProtKB:Q12948!28906934 GO:1901491 IEA GO_REF:0000107 Ensembl
114 133 UniProtKB:Q12948!28906935 GO:1901534 ISS GO_REF:0000024 UniProt
115 132 UniProtKB:Q12948!28906936 GO:1901534 IEA GO_REF:0000107 Ensembl
116 135 UniProtKB:Q12948!28906937 GO:1902038 ISS GO_REF:0000024 UniProt
117 134 UniProtKB:Q12948!28906938 GO:1902038 IEA GO_REF:0000107 Ensembl
118 136 UniProtKB:Q12948!28906939 GO:1904798 ISS GO_REF:0000024 UniProt
119 140 UniProtKB:Q12948!28906940 GO:1990869 ISS GO_REF:0000024 UniProt
120 139 UniProtKB:Q12948!28906941 GO:1990869 IEA GO_REF:0000107 Ensembl
121 54 UniProtKB:Q12948!28906942 GO:0005634 IBA GO_REF:0000033 GO_Central
122 2 UniProtKB:Q12948!28906943 GO:0000785 ISA GO_REF:0000113 NTNU_SB
123 3 UniProtKB:Q12948!28906944 GO:0000792 IDA PMID:15684392 UniProt
124 71 UniProtKB:Q12948!28906945 GO:0005634 IEA GO_REF:0000120 UniProt
125 56 UniProtKB:Q12948!28906946 GO:0005634 IDA PMID:11179011 MGI
126 57 UniProtKB:Q12948!28906947 GO:0005634 IDA PMID:11562355 MGI
127 58 UniProtKB:Q12948!28906948 GO:0005634 IDA PMID:11782474 UniProt
128 59 UniProtKB:Q12948!28906949 GO:0005634 IDA PMID:14506133 UniProt
129 60 UniProtKB:Q12948!28906950 GO:0005634 IDA PMID:14578375 UniProt
130 61 UniProtKB:Q12948!28906951 GO:0005634 IDA PMID:15277473 UniProt
131 62 UniProtKB:Q12948!28906952 GO:0005634 IDA PMID:15299087 UniProt
132 53 UniProtKB:Q12948!28906953 GO:0005634 EXP PMID:15684392 UniProt
133 63 UniProtKB:Q12948!28906954 GO:0005634 IDA PMID:16449236 UniProt
134 64 UniProtKB:Q12948!28906955 GO:0005634 IDA PMID:17210863 UniProt
135 65 UniProtKB:Q12948!28906956 GO:0005634 IDA PMID:19279310 UniProt
136 66 UniProtKB:Q12948!28906957 GO:0005634 IDA PMID:19793056 UniProt
137 67 UniProtKB:Q12948!28906958 GO:0005634 IDA PMID:20406990 UniProt
138 68 UniProtKB:Q12948!28906959 GO:0005634 IDA PMID:25786029 UniProt
139 69 UniProtKB:Q12948!28906960 GO:0005634 IDA PMID:26565916 UniProt
140 70 UniProtKB:Q12948!28906961 GO:0005634 IDA PMID:27804176 UniProt
141 55 UniProtKB:Q12948!28906962 GO:0005634 IC PMID:7957066 UniProt
142 72 UniProtKB:Q12948!28906963 GO:0005654 IDA GO_REF:0000052 HPA

The JSON archive retains the complete original WITH/FROM and extension objects; this table is only an index.

Review follow-up scope

The source-specific decisions distinguish an established biological function from an independently unresolved source assay. The P297S-letter and PMID:14506133 bending rows retain that uncertainty while explicitly acknowledging UniProt's curated attribution. This does not negate nuclear localization, transcriptional activation or DNA bending supported elsewhere.

The original PMID:11782474 author-uploaded paper, Results and Figure 5E plus the inhibitory-domain Discussion, distinguishes activation-domain-dependent attenuation from basal SV40 repression. The latter was not observed for the tested GAL4 DNA-binding-domain/inhibitory-region fusion. This narrows the interpretation of UniProt's activator-or-repressor summary without rejecting the experimentally supported inhibitory segment.

For NFIA (raw 39, stored 47), the positive nuclear-extract/probe-array association and the reviewed NFIA identity/class support GO:0061629. This is a partner-class refinement; the array is not a purified binary assay or the PBX1 co-immunoprecipitation experiment, and it did not establish NFIA-mediated inhibition. The other two supported generic associations remain non-core under the campaign policy where no evidence-backed functional subtype is established.

The two lens-transparency transfers (raw 84/85, stored 97/96) now carry probable WRONG_TERM queries, and stored 97 also records the exact UniProt mouse donor row Q61572!327843743. All request CHECK and remain NOT_REPORTED; no upstream report was sent and no corrected term was guessed. The Ensembl-assigned human IEA row uses resource OTHER with Ensembl named explicitly because the current schema has no ENSEMBL enum. The human ISS and original donor are assigned by UniProt. These queries concern corneal-versus-lens scope, not gene identity or a denial of the positive corneal experiments.

The original GO:1904798 row is a mouse Q61572 similarity transfer traced to PMID:25808752. It is not an experimental human PMID:26565916 row. The separate human evidence does not automatically establish the precise core-promoter scope. Official is_a ancestor queries for GO:0045944 and GO:0045893 exclude GO:0010628, preserving the existing distinction between positive gene expression and those specific transcription terms.

Source-specific consistency and partner resolution

The three PMID:19793056 contexts (stored 43, 66 and 116) and PMID:14506133 bending context (stored 82) remain UNDECIDED for their inaccessible original functional assays. The established gene-level functions and UniProt attributions are explicitly retained. This is an exception in evidence-access scope, not a claim that the biological functions are false. The current structured consistency_exception facility matches declared action-pair conflicts; its rules do not include these UNDECIDED pairs, so adding the field here would create stale-exception warnings rather than describe a recognized structured conflict. The rationale remains visible in each review and reference assessment.

The PMID:15684392 PBX1a row (stored 128) is refined from GO:0140297 to GO:0061629 using its own source-supported Pol-II transcription-factor partner class. Its original P40424-1 partner remains explicit, distinct from the accession-level PBX1 context in stored 46. Co-immunoprecipitation supports association; purified binary affinity and all-PBX1-product equivalence are not inferred.

The second core uses only the independently consulted human PMID:26565916 evidence. Reciprocal purified-protein pulldowns, endogenous BT549 co-immunoprecipitation and GLI2-dependent DNA-binding/promoter-occupancy/reporter results support the GLI2 regulatory mechanism. The proposed allosteric opening remains a model. Stored 52 is the GLI2 binding refinement; stored 122 is PITX2A and retains its separate partner context. Mouse PMID:25808752 is not substituted for the human mechanism or its unresolved source-specific core-promoter assay.

Official QuickGO queries retrieved on 2026-10-31 for GO:0045944 and GO:0045893, following both is_a and part_of, exclude GO:0010628. Sharing a regulation parent does not create that missing ancestry edge. The positive-gene-expression row therefore remains ACCEPT.

Reference relevance

Relevance records how a source informs FOXC1 biology; correctness and the explicit access notes separately record what could be verified. The direct P297S characterization remains HIGH despite unavailable assay text. The DSCAM citation is provisionally LOW for its inspected content while its original experimental assertion and unresolved citation question remain preserved.

Reference Relevance Role and access distinction
PMID:10474162(FOXC1-source-evidence.md#pmid10474162) MEDIUM Expression in developing mouse heart and human disease association support developmental context, rather than directly testing the molecular transcriptional mechanism.
PMID:11179011(FOXC1-source-evidence.md#pmid11179011) HIGH Human WT and patient-variant localization, cell-extract DNA binding and reporter assays directly inform FOXC1 molecular function.
PMID:11237714(FOXC1-source-evidence.md#pmid11237714) LOW Provisional to the inspected content: the authentic DSCAM abstract supplies no checkable FOXC1 functional result. The inaccessible full text and original FOXC1 annotation remain unresolved; this is not a finding of irrelevance, misattribution or a wrong identifier.
PMID:11562355(FOXC1-source-evidence.md#pmid11562355) HIGH Direct human-cell nuclear immunostaining and distinct mouse developmental experiments strongly inform FOXC1 localization and biological context.
PMID:11782474(FOXC1-source-evidence.md#pmid11782474) HIGH Direct human FOXC1 domain-mapping and reporter experiments establish activation, nuclear targeting and activation-domain-dependent attenuation.
PMID:12408963(FOXC1-source-evidence.md#pmid12408963) HIGH The authentic abstract directly reports FOXC1 growth-factor responsiveness and a re-expression phenotype in HeLa cells; access limits remain separate.
PMID:12614756(FOXC1-source-evidence.md#pmid12614756) MEDIUM A human clinical pedigree supports FOXC1 disease and developmental associations but does not directly establish a molecular tooth-development mechanism.
PMID:14506133(FOXC1-source-evidence.md#pmid14506133) HIGH The authentic abstract directly characterizes functional FOXC1 patient variants. Missing bending-specific Methods affect that claim’s verification, not the paper’s direct relevance.
PMID:14578375(FOXC1-source-evidence.md#pmid14578375) HIGH WT and L86 substitution assays directly examine FOXC1 nuclear localization, extract-based DNA binding and reporter output.
PMID:15277473(FOXC1-source-evidence.md#pmid15277473) HIGH Variant comparisons directly dissect FOXC1 wing-2 contributions to DNA binding and transactivation.
PMID:15299087(FOXC1-source-evidence.md#pmid15299087) HIGH Engineered FOXC1 forkhead-domain assays directly examine localization, DNA binding and transcriptional output.
PMID:15684392(FOXC1-source-evidence.md#pmid15684392) HIGH Target-specific FOXC1 partner, localization and reporter assays directly inform its regulatory interactions and their direction.
PMID:16449236(FOXC1-source-evidence.md#pmid16449236) HIGH FOXC1–PITX2A association and modulation assays directly inform a specific regulatory interaction.
PMID:16492674(FOXC1-source-evidence.md#pmid16492674) HIGH Human FOXC1 stability and reporter assays directly establish EGF/MAPK-dependent regulation of its output.
PMID:17210863(FOXC1-source-evidence.md#pmid17210863) HIGH Human WT/L130F localization, extract EMSA and reporter assays directly inform FOXC1 functional determinants.
PMID:17993506(FOXC1-source-evidence.md#pmid17993506) HIGH Endogenous human ocular-cell promoter occupancy, target reporters and knockdown directly support FOXC1 regulation of FOXO1.
PMID:18676636(FOXC1-source-evidence.md#pmid18676636) HIGH The authentic abstract explicitly reports a FOXC1 partner and confirmation/regulatory assays, directly informing its interaction biology despite unavailable full Methods.
PMID:19279310(FOXC1-source-evidence.md#pmid19279310) HIGH The authentic abstract directly reports a FOXC1 W152G functional characterization; uninspected assay details remain unverified.
PMID:19793056(FOXC1-source-evidence.md#pmid19793056) HIGH The verified title identifies direct characterization of the FOXC1 P297S variant. High relevance does not establish its inaccessible functional assays; correctness remains UNVERIFIED and three source rows remain UNDECIDED.
PMID:20406990(FOXC1-source-evidence.md#pmid20406990) HIGH Target perturbation and nuclear immunohistochemistry directly inform FOXC1 function in the specified breast-cancer models.
PMID:22190034(FOXC1-source-evidence.md#pmid22190034) MEDIUM The broad interactome and exact positive curated pair records corroborate a peripheral FOXC1 association, without establishing its core transcriptional mechanism.
PMID:22991501(FOXC1-source-evidence.md#pmid22991501) HIGH FOXC1 perturbation directly tests proliferation, epithelial-mesenchymal changes and migration in the studied cancer models.
PMID:25609649(FOXC1-source-evidence.md#pmid25609649) MEDIUM The original methods inform the interaction-screen context, but the exact FOXC1–PBX1 table entry remains unrecovered; this is supporting methodological context rather than independently verified target-pair evidence.
PMID:25786029(FOXC1-source-evidence.md#pmid25786029) HIGH Human WT/variant localization, binding and promoter-reporter assays directly inform FOXC1 transcriptional activity.
PMID:26565916(FOXC1-source-evidence.md#pmid26565916) HIGH Direct FOXC1–GLI2 binding and GLI2-dependent occupancy, DNA-binding and reporter assays establish a distinct regulatory mechanism.
PMID:27804176(FOXC1-source-evidence.md#pmid27804176) HIGH The authentic abstract directly compares human FOXC1 variants through functional assays; missing Methods do not make this a background-only reference.
PMID:27907090(FOXC1-source-evidence.md#pmid27907090) HIGH Human primary-keratinocyte perturbations directly establish FOXC1’s terminal differentiation context and expression hierarchy.
PMID:7957066(FOXC1-source-evidence.md#pmid7957066) HIGH Human FREAC3 forkhead-domain experiments directly establish DNA-site recognition and bending, within the tested fragment scope.
PMID:8499623(FOXC1-source-evidence.md#pmid8499623) MEDIUM The historical cloning and expression study establishes target identity and expression context; transcriptional activation was inferred and left for future assays.
PMID:9792859(FOXC1-source-evidence.md#pmid9792859) MEDIUM Human disease-associated variation supports developmental relevance, rather than directly establishing the molecular transcriptional mechanism.
PMID:10704385(FOXC1-source-evidence.md#pmid10704385) HIGH The authentic abstract directly describes Foxc1 renal/ureteric phenotypes and compound dosage, strongly informing the transferred developmental contexts.
PMID:28223138(FOXC1-source-evidence.md#pmid28223138) HIGH Direct Foxc1/Foxc2 podocyte phenotypes strongly inform a retained biological context; missing negative-transcription assay detail is a separate limitation.
PMID:24590069(FOXC1-source-evidence.md#pmid24590069) HIGH Foxc1-dependent mesenchymal niche formation directly informs its biological role; the precise positive-differentiation endpoint remains unresolved.
PMID:22171010(FOXC1-source-evidence.md#pmid22171010) HIGH Original mouse corneal stromal perturbations directly establish vascular-growth phenotypes and the cornea-versus-lens source-scope distinction.
PMID:25808752(FOXC1-source-evidence.md#pmid25808752) HIGH The authentic abstract directly addresses Foxc1 in Ihh–Gli2-dependent skeletal development; exact core-promoter assay verification remains limited.
PMID:18187037(FOXC1-source-evidence.md#pmid18187037) HIGH Foxc1 endothelial perturbation, receptor expression and chemokine-directed migration directly inform the donor contexts, with Foxc2-only ChIP kept separate.
PMID:19668217(FOXC1-source-evidence.md#pmid19668217) HIGH Human variation and mouse mesenchymal Foxc1 experiments directly inform the non-cell-autonomous cerebellar-development context.